Patients and public
Policymakers
Members
News and views
21 June 2019
New treatment option for recurrent non-infectious uveitis
Based on a new clinical trial, the National Institute for Health and Care Excellence (NICE) has recommended the use of a new treatment, the fluocinolone acetonide implant, which could lead to fewer hospital visits.
The clinical trial result suggests that fluocinolone acetonide implant may be able to improve clearness of vision for people with uveitis and help prevent the disease from returning.
Around 8,500 people in England have non-infectious uveitis, although the number eligible for the new treatment would be far fewer.
Read the full NICE recommendations here.
Stay up to date
Subscribe to
our newsletter
Get eye sector updates directly to your email inbox by signing up to our newsletter.
You can inform us at any time if you'd like us to stop sending you these communications.
Press enquiries
Media enquiries should be directed to [email protected] or call 020 7298 5151.
We are happy to put you in touch with our expert policy advisers who can comment on a variety of issues.
